Neurology
1 drug is in development for Nervous System Diseases.
- Companies
- 1
- Clinical trials
- 16
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Nervous System Diseases pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| nexiguran ziclumeran | Intellia Therapeutics, Inc. (NTLA) |
About this indication
Nervous System Diseases context
Neurology·MeSH: Nervous System Diseases (D009422)
Also known as: Disease, Nervous System, Disorder, Nervous System, Disorder, Neurologic, Disorder, Neurological, Disorders, Nervous System, Disorders, Neurologic, Disorders, Neurological
Frequently asked questions
How many drugs are in development for Nervous System Diseases?
BioSniper tracks 1 drug in development for Nervous System Diseases across 1 company.
How many clinical trials target Nervous System Diseases?
There are 16 clinical trials targeting Nervous System Diseases tracked by BioSniper.